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ABSTRACT
Arctic charr is a promising alternative aquaculture species in Atlantic Canada.
AJthough one of the factors which [mit the productivity of this species is microbial
diseases. it has been given very littie research attention.
The use of vaccines and antibiotics are the two methods available for protecting
fanned fish against microbial diseases. However, both methods suffer some
drawbacks, leading researchers to search for altemative methods for controlling
diseases.
Immunostimulants, a group of biological and synthetic compounds, have been
shown to increase non-specific activity in fish. The immunostinulatory effect of J}-
glucan from the yeast, Saccharomyces cerevisiae on non-specffic defences.
resistance to bacterial pathogen, Yersinia ruckeri infection. and growth in Arctic
chart, were investigated.
The effect on neutrophils and macrcphages was monitored after treatment by
injection with either 1 Of 10 mglkg and/or by immefSion in 1 or 10mgIL of glucan
suspension. Neutrophil activity was evaluated by their ability to stick to glass and
staining by Nitro Blue Tetrazolium (NBT). Maximum neutrophil activation was
observed 14 days after treatment by immersion in 1mgJL of gluca" suspension.
Phagocytic activity, which was assessed by Phagocylic Ratio (PR) and
Phagocytic Index (PI), was determined by ingestion of heat treated yeast cells by
Phagocytic activity, which was assessed by Phagocytic Ratio (PR) and
Phagocytic Index (PI), was determined by ingestion of heat treated yeast cells
by head kidney macrophages from glucan treated fish. Both PR and PI were
significantly elevated by immersion in 10mgIL between Days 2-14 as compared
to Day 0 and Days 21-35 after treatment
Effect on disease resistance was monitored after infection of fish by
intraperitoneal injection with Yersinia ruckeri. Glucan treated fish were
challenged on Days 1. 7 or 14 following immersion in 1mgIL of glucan
suspension. Treatment on 14 days prior to challenge resulted in higher survival
than on Days 1 and 7.
Maximum neutrophil and macrophage activation coincided with the day of
maximum survtvaL This suggests that disease resistance in Arctic charr may be
due to neutrophil and macrophage actiVation, which is stimulated by glucan
treatment.
Effect of glucan on the growth of the Arctic charr was also investigated in
this study. However. gluesn treatment of fish did not show any enhancement or
reduction of growth.
This study has demonstrated the potential of yeast gluesn as a method for
control of microbial diseases in Arctic charr.
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CHAPTER 1 • INTRODUCTION
1.1 GENERAL BACKGROUND
The world population is expected to reach close to seven billion by the tum of
this century, and estimates suggest that the capture fisheries will continue to
stagnate at its current level of about one hundred million toones annually. This
gives us every reason to believe that aquaculture will play an ever-increasing role
in providing resources for which the capture fishery has traditionally been relied
upon (Boghen, 1995). As food demand continues to increase, so must
production be intensified. Intensive methods of aquaculture production have been
therefore adopted to provide a reliable and sufficient supply of fish protein. These
methods are characterized by highly mechanized land and water based systems
combined with high stocking densities in many culture facilities. Inevitably. this
has often caused degradation of water quality due to accumulation of food and
metabolic wastes in the environment, coupled with the fast spread of pathogens
from host to host (Reichenbach-Klinke. 1973). These two factors have caused
wiele spread diseases in the aquaculture industry, resulting in devastating losses
in terms of fish, time and money. To avoid such losses, effective methods of
controlling infectious diseases have been sought.
There is also stiff competition for quality products within the industry, with only
those of highest qualities readling the international market For aquacutture to
grow, many products need to be developed to increase variety and reduce
competition. In Atlantic Canada, fish farming mainly concentrates on three
salmonid species: Atlantic salmon (Salmo safar), Rainbow trout (Onrorllynchus
mykiss) and Steelhead trout, a variety of Rainbow trout which can be grown in salt
water at some stages of its life-cyde. The high international competition for
marketing these species has resulted in the Canadian Atlantic salmon industry
receMng lower prices for it's products. Furthermore, one needs only look at the
recent decline of the northern Atlantic cod fishery to see what can happen when
an industry depends on one species. Introduction of new aquaculture species to
the region will add diversity as diffiaJlties of production or marketing of one species
will be offset by the success of another. The development of new products and job
opportunities will also be beneficial to the economy of a region that has been
severely depressed by decline of the capture fisheries (Brown, 1994: Brown et
aI., 1995). The introduction of species that win adapt wen to culture conditions,
grow rapidly and tolerate the cold water conditions of the region will expand the
potential number of suitable sites for aquaculture and provide avenues for Mure
economic growth.
Arctic charr, Salve/inus a/pinus is the most northern salmonid and the world's
most northerly spawning tresh-water fish. It is well adapted to extreme cold water
temperatures and demonstrates better growth at low temperatures than other
salmonids. Under culture conditions, juvenile Arctic charr have an advantage over
Atlantic salmon at water temperatures below 10DC because they grow three to six
times faster than Atlantic salmon of similar age (McGeathy and Delabbio, 1989).
Arctic charr has the added advantage of its ability to achieve high growth
performance under high stocking densities in intensive culture conditions, with low
densities showing significantfy lower growth and slightly higher mortalities than
higher ones. This has been associated with reduced antagonistic behavior and
stimulation of schooling behavior at high stocking density (Wallace et at, 1988). In
comparison to other farmed salmonids, charr have smaller heads relative to their
body size, therefore proc:luce a fillet yield of at least 7-8% higher than Rainbow
trout or Atlantic salmon (Delabbio, 1995). Fresh, fanned Ardic charr is a new
product in the market and is still considered a speciality item. warranting higher
prices than other commercialized salmonids. For these reasons, Arctic charr is a
suitable alternative candidate for cold water aquaculture.
Although interest in charr culture is high, commercial production is currentty
low. The reasons for this indude biological constraints such as fry survival, poor
egg viability and the lack of broodstock development programs (Glebe and Tumer,
1993). Research is currently focused on increasing egg viability, nutrition,
environmental aspects, fish husbandry and egg rearing.
Disease control is another area that has received little research attention. Prior
to development of resistance, Arctic chan- are more susceptible to Proliferative
Kidney Disease (PKD) than Rainbow trout and Atlantic salmon especially at
temperatures above 12 0 C (Brown et al., 1991). The species is also susceptible
to other baderial diseases such as Furunculosis, Vibriosis, Bacterial Kidney
Disease (8KD). Infectious Pancreatic Neaos;s (IPN). Enteric Redmouth (ERM)
disease, and other diseases that infed salmonids especially at sexual maturation
(Souter et. 1987; Hjeltnes. 1988; Erikson et. 1993; Groman. 1993).
Metacercariae of the digenean, Cryptocotyfe lingua, have also been reported to
infest land-lockecl Arctic chan- in Norway (Kristofferson, 1988). Metazoan parasitic
infections (Bouillon, and Dempsons, 1989) and nematode infection of the
swimbladder by Cysticola farionis (Giaever, 1991) have also been found to occur.
Diseases such as Furunculosis, 8KO, lPN, ERM and PKD have been
reported to affect freshwater and marine fish in Newfoundland, posing problems
tor aquaculture (Shaw and Hart. 1990). There is, therefore, a need to develop
effective methods tor controlling infections in Arctic chan- so that production of this
potentially viable species may be increased in the region.
1.2 DISEASE CONTROL METHODS
In aquaculture, it is important to take preventive measures to control losses
through microbial diseases. This can be achieved by maintenance of good water
quality and the use of vaccines. When prevention fails, therapeutic treatment is
given. However. extensive use of antibiotics has raised much concern for
consumer liability and for the development of antibiotic-resistant strains of bacteria
in the aquatic environment thus making further treatment difficult (Ward, 1982).
There is also a need to develop additional methods of disease control since
antibiotics are only effective in the treatment of some diseases such as
Furunculosis. ERM and Baderial Septicemias (And""""" 1992). Furthennore,
some antibiotics such as oxytetracyclines have been found to suppress the
irrmune responses in fish (Rijkers et at, 1981).
The use of chemicals for disease control has also raised some environmental
concerns. Use of chemicals, including salt (NaCl), results in release of large
quantities into the aquatic environment. use of focmalin. which is used against
parasitic and fungal infections of salmonid eggs, has been found to be
carcinogenic (Reic:henbach-Klinke and landott. 1973). The success of chemical
treabTlent is usually achieved at levels that result in accumulation of toxic
chemicals in the environment A major disadvantage to the use of both antibiotics
and chemicals is that b'eatment is usually started after the outbreak of disease has
been confirmed, at which time a significant proportion of fish have been infected.
thus increasing costs of treatment
Promotion of disease resistance and maintenance of individually acquired
immunity, which depends on production of antibodies, can be stimulated by
vaccination (Robertson et at, 1990a). However, this has some disadvantages.
Vaccines have been developed for some bacterial diseases such as Hitra disease
but not for others of commercial importance such as Bacterial Kidney Disease
(8KD) and for viral diseases. In cases where fish are susceptible to more than one
disease, multivalent vaccines are usually required. This makes vaccination an
expensive exercise. In addition. the method cannot be used when the
pathogenic agent is unknown. Therefore, researchers continue to seek other
ways for controlling microbial diseases in fanned fish, including Arctic charr.
1.3 DISEASE DEFENCE MECHANISMS IN FISH
In identifying effective methods for disease control in aquaculture, an
understanding of the natural defence mechanisms of fish is necessary. Vv'hile
these can be categorized into specific and non-specific factors, it is important to
note that in vivo, the two are interdependent in many ways and the sum total of
defence factors responsible for immunity to a particular disease is a highly
complex interrelationship of specific and non-specffic defences (Roberts, 1989).
Specific factors, also referred to as acquired or adapted. include T-eel/s, B-cells
and immunoglobulins, and are characteriZed by an ability to acquire memory and
specificity towards a pathogen (Engstad. 1994). They require adaptive changes
in the lymphoid system and form the second line of defence (Roberts, 1989).
Non-specffic defences include surface barriers. a variety of humoral defense
mechanisms and cellular aspects such as phagocytic cells which indude
maaophages, monocytes, neutrophils and cytotoxic cells (Robertson et at, 1990;
Anderson et at, 1992; Engstad 1994). They lack the ability to acquire memory
and specificity towards pathogens and form the first line of defence since they are
part of the normal body constituents (Ward. 1982). Due to the complex nature of
antibody synthesis combined with dependence on temperature, specific defences
take longer to develop (Anderson and Jeney, 1992). Furthermore, antibodies
have a restricted diversity and lack the ability to mature in fish (Wilson and Warr.
1992). Non-specific defences are therefore relatively more important to fish
compared to higher vertebrates. especially for short-lived cool or cold water fish.
1.3.1 Sur1llce baniers and humoral factors
The skin and gills of fish are covered by a mucous layer which contains lytic
enzymes that are toxjc to certain micro-organisms. They also have epithelial ceUs
which are highly responsive to chemical or physical damage; resufting in
thickening of the cutide. or hyperplasia. Mucous membranes lining the
gastrointestinal tract. act as a banier which combine with the digestive enzymes
and low pH of the gut, to provide an unsuitable environment for potential
pathogens (Rober1s, 1989).
Non-specific humoral factors consist of proteins found in body fluids, whose
protective role is achieved either by reacting with microbes and microbial products
to inhibit their growth, or by neutralizing enzymes on which the pathogens depend.
They include enzyme inhibitors found in tissue fluids and bkxxf serum. growth
inhibitors, Iysins. precipitins and agglutinins (Anderson. 1992).
1.3.2 Cellular factors
In fish. cellular responses consist of phagocytes and non-specific cytotoxic
cells. Phagocytes include mononuclear cells and granulocytes. the former
consisting of monocytes and macrophages. Monocytes are found in the blood and
kidney where they form the precursofS of macrophages. Macrophages are
mononucleated tissue cells with undulating membranes and are highly phagocytic
or pinocytic, and have adherence abilities to glass and plastic surfaces. Some fish
macrophages, known as melanomacrophages, contain melanosomes and are
believed to have a bactericidal role (Ellis, 1976; 1971). Monocytes have the
ability to migrate from the blood to inflammatory sites where they give rise to
macrcphages, which are phagocytic for foreign substances such as yeast
(Pulsford et al.. 1994; Yuwaraj et al.. 1994). sheep red blood cells (Sovenyi and
Kusuda. 1987; Anderson and Jeney. 1992), and bacteria (Kitao and Yoshida,
1986).
Fish granulocytes include neutrophils. eosinophils and basophils. Neutrophils
are associated with defence of fish from fungal and bacterial infections (Wood et
at, 1986; Lamas and Ellis, 1994). A Criterion for provisional identification of the
neutrophils are the presence of a grey cytoplasm in cells stained wTth Wrighfs
stain, a nucleus with 2-5 lobes and peroxidase positive cytoplasmic granules.
They derive their name from the inability of their granules to stain markedly with
either acid or basic dyes (Finn and Nielson 1971). Although the major
granulopoietic organ is the kidney, the spreen may also playa role. Anderson et
at (1992) reported phagocytic ability, diapedesis and oxidative radical production
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of neutrophils. Phagocytosis can be detected by the engulfment of particles.
Diapedesis. or active migration from the circulatory system towards an injury site,
can be assayed by the cells' ability to adhere to glass. Oxidative radical
production, which is directed at the destruction of iwaders. can be detected by
chemiluminescence or Nitro Blue Tetrazofium (NBT) staining.
The glass adherent ability of activated circulatory neutrophils combined with
their production of reactive oxygen species (ROS) such as superoxide anion. (021,
hydrogen peroxide (H2.~' activated or singlet oxygen (01. and free hydroxyl ions
(OH") can be monitored by the glass adherent Nitro Blue Tetrazolium (NBT)
staining method described by Anderson et at (1992).
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1.4 IMMUNOSTlMULANTS
Unlike vaccines which function in controlling disease by biggering production of
specific antibodies towards particular organisms. a group of biological and
synthetic compounds have been found to enhance the non-specific defence
mechanisms in fish and other animals by their immune-stimulatory action. These
compounds are known as immunostimulants. They provide an important method.
which may be the answer to the future of disease control in aquaculture.
An immunostimulant has been defined as a chemical. drug, stressor. or
action that elevates the non-specific defence mechanisms or the specific immune
response. By themselves. immunostimulants activate nonspecific defenses.
They can also be administered with a vaccine to elevate specific immune
responses. They are given by injection, immersion or orally in feed components.
Immunostimulants have sometimes been classified as biological response
modifiers as they cause immuno-modulation by stimulation or suppression
(Anderson, 1992).
lmmunostimulants for fish have been obtained from various biological and
synthetic sources. Important biological sources include bacteria (AJcaJigenes
faecaJis; A. 1evanicum), yeast (Saccharomyces cerevisiae) and filamentous fungi
(Sclerotium glucanicum, Schizophyflum commune) (Yano et at, 1991). Synthetic
"immunostimulants of importance in fish include the synthetic peptide. FK·565
(hepatonoyJ-y-D-glutamyt..{L) mesodiamiopime¥-<O)-alanine}, 15K (a short-chain
polypeptide) derived from fish products, CFA (Complete Freund's Adjuvant) •
paraffin oil and killed tubercle bacilli, OAC (Quaternary Ammonium Compounds),
Ievamisole (Ievo-isomeroftetramisole), and grucans (Anderson. 1992).
1.5 YEAST GLUCANS
These are insoluble, long chain polysaa:harides, which form important
structural components in the ceO wan of most yeasts and fungi. Their ability to
stimulate non-specific defences in fish has been investigated by several authors
including, Robertsen et at (1990), Yana et at (1991), Engstad et al. (1992),
Jorgensen et al. (1993), Janey and Anderson (1993), and Brattgjerd et at
(1994).
Glucans are extracted from whole pressed cells of bakers yeast by a series of
processes that involve removal of mannan, and precipitation and removal of
glycogen. Structural analysis by methylation. periodate oxidation and enzyrT10tysis
has shown them to have a branched structure made of (1 <iJ6}-linked P-glucose
residues to which are attached linear side chains of (1 <8J3)-linked (!--glucose
IJ
residues (Figure 1). The (1 <XI3Hinked side chains are a major component.
forming aboot 85% of the finkages (Duffus et aI., 1982).
Gluca" is known to stimuJate defence mechanisms in vertebrates and
invertebrates. FISh have developed a mechanism for recognition of glucan. which
has evolved as a mechanism for defence against fungal pathogens (Onarheim,
1992). Robertsen et al. (1990a) have demonstrated enhanced resistance to
infection by V;brio saJmonickJa. Vibrio angui/larium and YefSl"nia rockeri in glucan
injected Atlantic salmon. Bactericidal activity by macrophages of glucan-treated
Rainbow trout has also been demonstrated (Jorgensen et at, 1993b). Niki et al.
(1992; 1993) have shown its ability to improve effectiveness of furunaJ)OSis
vaccines while Engstad et al. (1992) have demonstrated it's ability to stimulate an
increase in tysozyme and complement-mediated haemolytic activity. Stimulatory
effects of gluca" have been attributed to its activation on the phenoloxidase
(proPO) system in shrimp (Penaeus monodon), which represents the terminal
components of a complex cascade of enzymes that function in non-self recognition
and host defence (Sung et aI., 1994).
'3 3'
r r
..!, ~.
I
G-(1-+3HG], i1-+3HG],
Figure 1. Partial Structure of yeast gfucan. G denotes a Il-D-glucopyl'3nose
residue, and x + y = 40-50 (adapted from Duffus et al" 1982).
14
IS
Fish macrophages are able to recognize 1J-1,3- glucan structures in yeast cell
walls either directJy through a specific receptor. or indirectly by binding with
complement The branched structure of QrUC3n is of importance in eliciting
stimulatory effects in macrophages which have receptors that can recognize the
side chains of gluesn molecules. This has been demonstrated by the low
stimulatory effects of glucans with few or no side chains (Engstad and Robertsen,
(1993).
GluC8n has also been shown to stimulate growth. The effect on growth is
based on the assumption that glucan treated fish are healthier and thus grow
faster. However, Matsuo and Miyazono (1993) found that peptidoglycan, a type
of glucan derived from cell walls of gram-negative bacteria, enhances resistance
of juvenile Rainbow trout against Vibrio anguillarium infection, but does not
influence growth. It has nonetheless been reported to be effective in enhancing
growth of shrimp, whose mechanism for better growth was attributed to higher
disease resistance (Sung et at. 1994).
Much of the research work done on immuno-stimulation by gJucan in fish has
focused on it's ability to increase protection from microbial infection. Rainbow trout
and Atlantic salmon fed with diets containing glucan have shown reduced losses
from disease (Onarheim and Roberts, 1992). Commercialization of ~Jucans is
currently in the form of feed supplements (Lall and Olivier, 1995). Stimulation of
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immune response by oral administration is associated with the presence of
lymphoid tissue in the gastrointestinal tract., whidl processes P-Qlucan particles
using the mucosal immune system's (MIS) phagocyte system. Trials wtth diets
containing lJ-glucans have shown inaeased non-specific activity such as number
of lymphocytes and phagocytic activity in macrophages of Channel catfish
(/ctafunIS punctatus) (Duncan and Klesius, 1996).
Studies with fish have shown that gluca" improves the efficiency of vaccines
compared to the vaccine alone. The survfval of Atlantic salmon (Sa/rna safar)
challenged with large numbers of pathogens of diseases such as Hitra. Vibriosis
and ERM disease has been shown to improve after glucan treatment (Mitchell,
1992).
1.6 RATIONALE AND AIM OF STUDY
To meet the current demand for aquaculture products, the Canadian
aquaculture industry needs to diversify its product lines and to reduce losses in
culture facilities. Arctic charT has been found to be well adapted to the cold waters
of the region. demonstrating better growth than Rainbow trout or Atlantic salmon
at water temperatures below 10 0 C (McGeathy and Dellabio. 1989; Wallace,
1990). It performs well under high stocking densities (DeJabbio, 1995), has higher
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yiekts, and fetches higher prices than other salmonids. It is, therefore. a
promising candidate for QJlture and global production of char will most likely
continue to increase.
Although interest in culture of Arctic charr is high, commercial production is
low. This is attributed to biological constraints such as poor fry survival and egg
viability and lack of blOOdstock development programs (Glebe and Tumer, 1993),
Another potential setback to production is the financial loss due to infectious
diseases. Disease control has received litUe attention even though all diseases
common to other salmonids also occur in Arctic charr (Vreira, 1989).
The aim of this study was to investigate the effect of an immunostimulant,
Maaogard~. a J}-1.311,6 -glucan, which is derived from the cell walls of a yeast,
Saccharomyces cerevisiae, on non-specffic defences, growth and survival in
Arctic charr. Survival was detennined by challenge with the bacterial pathogen,
Yersinia ruckeri, the aetiogical agent for ERM disease, which has been partly
responsible for financial loss suffered by the aquaculture industry (Newman and
Majnaricl1, 1992),
"CHAPTER 2 - MATERIALS AND METHODS
2.1 FISH
Juvenile Arctic charr, 'Neighing approximately 95g, were obtained from the
Arctic Chart Hatchery, Daniel's Harbour, Newfoundland. Canada. They were
maintained in a flow through system in 1m3 circular fi)erglass tanks at the Marine
Institute of Memorial University. Water flow was regulated at a rate of 2l per
minute. The water was aerated with supplemental oxygen and its temperature
maintained at 12 ± 1°C. Fish were held at a stocking density of 60 kgtm3 and were
fed to satiation twice a day on Alpine feed (Moore Clarke Co. Canada fnc.) unless
otherwise stated.
2.2GLUCAN
Macrogaro-, the !}-gluesn (2.5%) used in this study, was provided through the
courtesy of Biotec Mackzymal. Tr0mso. Norway. Glucan was prepared from the
cell walls of yeast. Saccharomyces cerevisiae ( 2.5%) and preserved in formalin
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(0.2%). For preparation of required doses. it was diluted with Phosphate Buffered
Saline (PBS. pH 7.4).
2.3 ADMINISTRATlON OF GLUCAN
Glucan was administered by injection and immersion methods. Feeding was
withheld a day before and after each time fish were treated with glucan. Fish were
anaesthetized with MS-222. Fioque! (100mgll) before injection with glucan.
Fish were treated with gluesn by either injection or immersion. For injection of
glucan, the ventral surface of the fish was swabbed with 70% alcohol prior to
treatment Two groups of fish were injected with 2ml of either 1 or 10 mglkg
glucan suspension. A third group was injected with 2m1 PBS (0 mglkg) and
served as the injection control. For immersions. two groups of fish were removed
from their respective tanks and placed into buckets containing 1 or 10mg1L glucan
suspension supplied with supplemental oxygen and held for 30 minutes. A third
group was immersed in fresh system water (0 mgIL) supplied with supplemental
oxygen for 30 minutes and served as the immersion control. A fresh glucan
immersion was prepared for every group of ten fish. Fish were held in recovery
buckets containing 12°C system water and supplied with supplemental oxygen for
thirty minutes before being returned to their respective tanks.
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2.4 NITRO BLUE TE"TRAZOUUII (NBT) ASSAY
FIVe fish from each gluesn treated and non-treated control group were
randomly sampled for the presence of glass--adherent. NBT-positive neutrophil
celts. The fish were sacrificed by using MS-222 (200mgA..) one day prior to
treatment (Day 0) and 14 and 28 days after treatment with glucan thereafter.
Approximately 0.1 ml of blood was withdrawn from the caudal peduncle of each
fish into a syringe containing lithium salt heparin from porcine intestinal mucosa
(Sigma Chemical Company. St louis), and immediately placed on two glass
cover slips. The cover slips were placed in 60 mm petri dishes lined with wet
paper to'tYeIs to maintain humidity (FIQure 2). They were incubated for 30 minutes
at room temperature (22 ± 111C). The cover slips were washed gently with PBS
then transferred upside down to a miaoscope slide containing a drop of 02%
filtered NBT solution (2-2'.()i-p-nilrophenyl-5-5'-<liphenyl-3,3'13, 3', dimethoxy-4,4'-
dipheny1eneJ ditetrazolium chloride), C.,H",CI,N"O., (Sigma chemicals Co., St
Louis, USA). After 30 minutes. the number of glass-adherent neutrophils were
detennined from three random fields for each slide.
"2.5 PREPARAnON OF YEAST CElLS
Yeast cells, for the phagocytic assay, were prepared by the method adopted
from Namaware et at (1994). Twenty grams of bakers yeast (S. cerevisiae) was
mixed with 20 ml 0.15 M PBS and inactivated by heating in a water bath at 80 0 C
for 15 minutes. The ceDs were washed three times in 5 ml PBS by centrifuging at
15, 300 x 9 for 10 minutes ($orvall centrifuge, Ou Pont instruments. USA). The
supernatant was decanted. the yeast cell pellet resuspended in PBS and then
mixed using a vortex mixer (FISher Scientific, Fair Haven. New Jersey). Cells
were counted on a Naubauer improved haemocytometer (Oynatech, West
Gefmany) and diluted to 12x1011 cellslml with PBS. After the final supernatant
was decanted, cells were resuspended in sterile l-15 medium (Sigma Co.)
containing 4% fetal calf serum, 10 unitslml of heparin lithium salt from porcine
intestine mucosa (Sigma Chemical Company, St Louis) and 100units Iml
lyophilized. y-frr'adiated and sterile peniciUin-streptomycin (Sigma Chemical
Company, St louis. USA).
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2.6 PHAGOCYTIC ASSAY
Five fish from each group were sacrificed by immersion in 200mgIL of M5-222
(Finquel) on Days 0, 2. 7, 14, 21, 28. and 35. About 2 em of the posterior
portion of the kidney was excised and placed in a petri dish containing L-15
complete medium with 2% fetal cart serum, 100 unitslml of penicillin/streptomycin
and 10 unitslml heparin. Macrophages were isolated by the method described by
Namaware et at (1994). Kidney samples from each treatment were pooled as it
was not technically pradical to perform macrophage activation assays on
individual fish due to the time-oJosuming nature of the assays. Samples were
pressed through a 100J.llll wire mesh wfth 4 ml of complete L-15 medium to make
a pronephric cell suspension. One ml of the kkfney cell suspension from each
treatment was flooded onto individual pre-washed microscope slides and
phagocytic cells allowed to adhere for 60 minutes at room temperature (22 ± 1°C).
Non-adherent cells were washed off with PBS and the attached macrophages
were flooded with 1 mI of yeast cells in L-15 medium containing 4% fetal calf
serum. Sixty minutes later, the sJides were rinsed with PBS. Cells were stained
with Wrights stain modified (0.3 % wlv, pH 6.9) (Sigma Diagnostics, St Louis,
USA) then examined under oil immersion. Phagocytic activity of macrophages
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was determined by Phagocytic Index (PI) and Phagocytic Ratio (PR) (Vano et al..
1989).
For each slide, two hundred macrophages were examined to detennine the
PI as:
PI "'" no of macrophages ingesting yeast cells x no of yeast cells ingested x 100
200 200
From the examined cells. the percentage of macrophages which engulfed one or
more yeast cells was detecmined to give percent (%) phagocytosis, also referred
to as Phagocytic Ratio (PR) as:
PR _ nQ gf macrnphaees ingesting at !east one yeast cell x 100
200
2.7 GROWTH STUDIES
FISh were held at a stocking density of 60 kglm3. Individual fish were
identified by using Carting tags. Wet weight(g) measurements were taken using
an electronic balance (A & 0 company, Tokyo. Japan) one day prior to treatment
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with gluca" (Day 0) and on 30, 56, and 78 days thereafter. Length
measurements were taken using a measuring board on the first and last days of
weight measurements. Fcsh were fed two times a day on Alpine feed (Moore
Clar1(e Co. Canada Inc.) at a 2% body weight ration per day. Specific Growth Rate
(SGR) was determined according to Efthimiou (1996):
Specific Growth Rate = In final weight Cg) - In initial weight (0) x 100
time (days)
2.8 CHALLENGE WITH BACTERIA
2.8.1 Culture of baet8ria. confinnation of identity and virulence
Yersinia ruckeri, originally isolated during the summer of 1992 from a dead
salmon at Conne River, Bay d'Espoir, were obtained from the Department of
Fisheries and Oceans (DFO), St John's. Newfoundland, Canada.
TIle pathogen was maintained on Trypticase Soy Agar (TSA) then
characterized by using conventional biochemical methods. Virulence of the
pathogen was enhanced by intraperitoneal (IP) injection of 10s to 106 CFU of
viable bacteria into each of x fish. The bacteria were re-isolated on TSA from
2S
infected fish and similarity with the original isolate was established biochemically
by the API 20e- system (BioMtrieux. France). The cultures were maintained on
TSA slants under stene mineral oil for use as the starting inoculum for all studies
with the pathogen.
2.8.2. Oetennination of growth eharacteristica of ¥elS;nia rucke,;
A Ioopful of Y. ruckeri was thawed then aseptically transferred from a vial to
Tryplicase Soy Broth (TSB) and incubated at 20 ± 1 0 C for 24 hours. One tenth of
ami of this culture was used to inoculate a 250 ml Er1enmeyerflask containing 100
ml of sterile TSB. The flask was incubated at 20 ± 1 0 C with gentle agitation on a
gyratory shaker (Scientific Indusbies, NY, USA). Samples were aseptically
removed from the flask for determination of cell concentration. The first sample of
1ml was removed thirty minutes after inoculation and every thirty minutes
thereafter until the onset of the stationary phase of growth. Absorbence of
bacterial suspensions was measured by a photoelecbic colorineter (Klett
Manufacturing Incorporated., USA) using the TSB as the reference solution for
calculation of Optical Density (00) of the culture as:
0.0 =colorimeter reading x 0.02
2.
Optical density values were used to detennine the logarithmic phase of growth of
Y. rockeri. Bacteria from the mid-log phase of growth was used for infecting fish in
the challenge experiment (section 2.8.5).
2.8.3 Detennination of concentration of Yersin;' I1ICkeri for challenge
experiment
Cultures of Y. rockeri were harvested at the mid-log phase of growth (section
2.8.2) by centrifugation at 15,300 x 9 and 10,000 rotations per minute (Ou Pont
Instruments. USA). This was done at 4 0 C tor 20 ITlfnutes. The supematant
medium was decanted and autoclaved before it was discarded. The bacterial
pellet was resuspended by manual agitation in sterile distilled water. Ten-fold
dilutions of the suspended bacteria were prepared in sterile disposable screw cap
tesHubes with sterile distilled water.
One ml of each of the 107 and 10' bacterial suspensions was pipetted onto
triplicate, TSA plates. Twenty mJ of motten (45--48°C) agar was poured onto the
suspensions and agitated to ensure uniform mixing of the suspension and molten
agar. After solidification of the agar, the petri plates were inverted. labeled and
incubated at room temperature (21 ± 1°C) for approximately 48 hours. Plates
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having between 30-300 colonies were counted using a dark-field colony counter
(American Optical Company, Buffalo, N.Y.). The concentration was calculated
from the number of colonies counted. which corresponds to the number of Colony
Forming Units per ml {CFUIrnl} of bacterial suspension and the dilution as:
CFU/mi :,;: Dilution x number of comnies counted
2.8.4 Oetennination of rou18 and dose of bacteria for artificial infection
A preliminary experiment was performed to determine the appropriate
concentration of baderia and route of administration for challenge (section 2.8.5).
A randomized design of six groups each with eight fish was set up. Two groups
were exposed to 2.4x10 T and 2.4x10' CFUImI immersion and four groups were
injected with 2.4x1015 , 2.4x10T, 2.4x10', and 2.4x1011 CFU of bacteria in 0.1 mI of
0.85% NaC!. Before injection with bacteria, fish were anaesthetized with 100mgA.
M5-222 then swabbed with 70% alcohol on the ventral surface. FISh were moved
into the experimental facility two weeks before the study to permit recovery from
handling and to allow accfimation to the new environment Feeding was withheld
during the 24 hour period immediately prior to infection.
28
Bacterial suspensions for the preliminary challenge study was prepared as
follows: Y. ruckeri previously isolated from Arctic chaIT artfficially infected by
intraperitoneal injection was re--plated from TSA slants onto TSA plates for 24
hours. A well isolated colony from the plate was aseptically inoculated into a test
tube containing 10 ml of TSB and incubated at room temperature (20 ± 1ClC) for 8
hours with gentle agftation on a shaker (Scientific Industries. NY). One tenth of a
ml of the culture was aseptically inoculated into a flask containing 100 ml sterile
TSB and inaJbated as above. The culture was transferred to a 250 ml sterne
centrifuge bottle and centrifuged at 5000 x 9 at 10 ± 1ClC for 30 minutes. The
supernatant medium was decanted, autocfaved and discarded.
The pellet was resuspended in 0.1 mI of 0.85 % saline and mixed gentfy on a
shaker to make a baderial suspension of 2.4 x 1010 CFU in 0.1 mI of injectable
baderial suspension as obtained in section 2.8.3, then serially diluted to make
bacterial suspensions for infection by the injection route. The same procedure was
followed for infection by immersion, however. the pellet was resuspended in 100
ml saline, the original volume of the culture solution and diluted tefl..fold to give
two bacterial concentrations for infection by immersion.
Water temperature was gradually raised from 10 to 1SOC before infection with
bacteria. Each immersion bucket had 4950 m[ of vigorously aerated flow-through
system water to which 50 ml of the bacterial suspension was introduced to make
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the required final concentration. FISh were introduced into respective buckets.
which were supplied with supplemental oxygen for thirty minutes. with buckets
covered to reduce excitation and stress. Clinical signs of oxygen inadequacy and
other stressors were checked periodically. Before being returned to their
respective tanks, fish were held in recovery buckets containing fresh system water
and suppfied with supplemental oxygen.
Observations were made twice daily. Mortalities were removed and recorded
daily. External and internal signs of infection and other possible causes of death
were recorded. Bacterial pathogen was isolated from dead fish and identified
using API 20E biochemical system (Biomerieux France).
2.8.5 Challenge of Arctic eharr with Y.,.;n;' roenli
Challenge experiments were carried out at the Marine Institute's quarantine
facility. Four-hundred and twenty fish of 30-40 9 average weight were maintained
at 10°C in 0.5 m3 fiberglass tanks. Temperatures were raised to 15°C before
bacterial infection. FISh were randomly distributed into six groups of 70. each
representing a treatment orco~ group for challenge on Days 1. 14 and 21 after
glucan treabTlenl Treatment was done by immersion in 1mgIL of glucan
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suspension for thirty minutes, which was found to be most effective in activating
neutrophils (sections 2.4 and 3.11).
FtSh were injected with 2.4 x 107 CFUlml of Y. rockeri. whid'l was the most
effective tor artificial infection (sections 2.6.4 and 3.3.4). Mortalities were recorded
on a daily basis and isolates from kidneys obtained for pathogen identification
(section 2.8.1) to verify the cause of death. Resistance to infection was reported
as Relative Percent Protection (RPP), which was calculated by the following
method adopted from Robertson et at (1990):
RPP = [ 1 - (% morta![ty in glycan treated groyp> ] X 100%
( % mortality in control group)
2.9 STATISTICAL ANALYSIS
Mean and Standard Error of Mean (SEM) were calculated for activated
neutrophils. For PI and PR, means were calculated for each group. Statistical
analysis of data was pel'fooned using one way Analysis of Variance (ANOVA) for
determination of significant differences between control and experimental groups
(P<O.OS). The Least Significant Difference (LSD) method of multiple comparisons
was used to identify responses that were significantly different Mortalities in
"different groups of fish infected with bacteria were compared by Chi-square (x2)
tests (P<O.05) (Zar, 1996). All data was anatyzed with the of MicrosoftCi Office
Excel statistical program Version 5.0.
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CHAPTER 3 - RESULTS
3.1 EFFECT OF GLUCAN ON NON-SPECIFIC CELLULAR RESPONSES
3.1.1 Neutrophil activation
Activated neutrophifs were identified according to descriptions by Schreck
and Moyle (1990) by the presence of a greyish·blue cytoplasm and presence of
many small granules which stained dark-blue with NaT with 0.2% NBT stain in
PBS. Nudei were frequently bilobed and eccentrically positioned, with a
spherical or horse-shoe shape. They were relatively large. forming about 30-50
% of the total cell size. The shape of the cells varied from spherical to ovoid and
sometimes showed pseudopodia.
It was observed that immersion in 1 and 10mgIL. of glucan resulted in
neutrophil activation (F=12.91, df=5, P<O.05) 14 days following treabnent.
(Figure 3 and Table). However, among the groups treated by injection, only
the group that received 10 mglkg resulted in significant activation of circulatory
3J
neutrophils (Figure 4 and Table 1). This indicates that immersion is more
effective than injection as a route of glucan administration in Arctic charr.
Neutrophil activation on Days 1 and 28 after glucan injection or immersion
was not significant (P>O.05). Overall. the stimulatory effect of glucan on
neutrophils was highest on Day 14 following immersion in 1 mgll (Table 1 and
Figure 3).
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Figure 3. Activated neutrophils in Arctic charr (5. a/pinus) at O. 14 and 28
days after treatment by immersion in a mglL f· .....}. 1 mgll... (---+-)
or 10mgIL. (---e----·) glucan suspension. Results are expressed as means.
Vertical bars are standard error of mean. N=3 for each group.
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Figure 4. Activated neutrophils in Arctic charr (5. a/pinus) at O. 14 and 28
days after treatment by injection with 0 mgl1<g (....-..... ), , mgl1<g( ----+--- ) or
10mglkg +---a-) gluean suspension. Results are expressed as means.
Vertical bars are standard error of mean. N=3 for each group.
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Table 1. Activated neuttophils in blood of glucan treated Arctic charr (S.
a/pinus). Means and standard deviation are indicated. Significant activation is
indicated by • (P < 0.05).
Method of Days after
administration Dose treatment
14 28
Injection Omglkg 0.47 ± 0.97 0.67 ± 0.0 O.50±O.19
1mglkg 0.43 ±0.10 0.87±0.19 0.80 ±0.36
10mglkg 0.67±0.16 1.73±O.16 0.80 ± 0.36
Immersion OmgIL 1.07 ± 0.25 0.97 ± 0.10 0.87 "0.23
1mgIL 0.67±0.12 3.23 ± 0.50· 1.13±0.31
10mgIL 0.50 ±0.19 1.43 ±O.28 0.87" 0.06
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3.1.2 Phagoeytic activity by macrophag...
Phagocytic activity by macrophages isolated from Arctic charr was expressed
as Phagocytic Ratio (PR) and Phagocytic Index (PI). Both macrophages and
neutrophils were observed under the microscope, but for purposes of this study,
only macrophages were counted.
Macrophages were identified by the possession of numerous membrane
bound cytoplasmic granules which stain dark blue with NBT and have many
vacuoles and pinocytic vesicles. They also have nuclei which were often
eccentric and varied from horse-shoe to brain shaped. The cytoplasm is
greenish-blue, and characterized by many coIour1ess cytoplasmic vacuoles
possibly containing accumulations of ingested material. The cells have irregular
membranes and vary in size and shape from oval to spherical (Schreck and
Moyle, 1990).
Phagocytized yeast cells were quantified by washing the slides with PBS to
remove non-phagocytiz.ed yeast cells and then counting the remaining yeast
cells.
There was no activation prior to glucan treatment (Day 0) and on Days 21-
35 after treatment. PR was significantly increased between 2-14 days by
J8
immersion in 10mgiL (ANOVA, F=53.91, P<O.05). There was no increase in
PR by other treatments (Figure 5, Table 2).
When measured by PI, maaophage activity was significantly higher
(ANOVA, F=154.98, P<O.OS) during the 2-14 days in the groups treated with 10
mgIL of glucan by immersion. PI for other groups was not significantty increased
during this period) (Figure 6, Table 3).
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Figure 5. Phagocytic Ratio (PR) of head kidney macrophages isolated from
glucan treated Arctic chaIT (5. a/pinus) on Days 2-14 ( 0 ) or Days 21-35 ( 0 )
after glucan treatment • indicates significantly activated macrophages
(P < 0.05).
Tabkt 2. Phagocytic Ratio (PR) of macrophages isolated from glucan treated
Arctic charr(S. a/pinus). Phagocytic assays were performed on Days 0, 2. 7,
14, 21, 28 and 35 afterglucan treatment samples for Days 2-14 and 21-35
were pooled.• indicates significantly activated macrophages (P < 0.05).
Method of Days after
administration Dose treatment
0 2-14 21-35
Injection Omglkg 0.00 17.50 11.33
Imglkg 0.00 23.00 6.83
10mglkg 0.00 28.83 6.83
Immersion OmgIL 0.00 21.17 11.83
ImglL 0.00 24.00 14.67
10mgIL 0.00 41.50· 10.83
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Figure 6. Phagocytic index of head kidney macrophages isolated from gluesn
treated Arctic charr (5. sfp;nus) on Days 2-14 ( 0 ) or Days 21-35 ( 0 ) after
glucan treatment. .. indicates significantly activated macrophages (P < 0.05).
Table 3. Phagocytic Index (PI) of macrophages isolated from glucan treated
Arctic charr (S. a/pinus). Phagocytic assays were perfonned on Days 0, 2. 7,
14, 21, 28 and 35 afterglucan treatment. Samples for Days 2-14 and 21-35
were pooled... indicates significantly activated macrophages (P < 0.05).
Method of Days after
administration Dose treatment
0 2-14 21-35
Injection Omglkg 0.00 2.12 1.31
1 mglkg 0.00 5.02 0.47
10mglkg 0.00 5.20' 0.39
Immersion OmgIL 0.00 3.05 1.44
1mgIL 0.00 3.84 1.66
10mgIL 0.00 8.37" 0.93
42
43
3.2 EFFECT OF GLUCAN ON GROWTH
All treatment groups exhibited positive growth throughout the trial as shown
by wetght measurements (FlQure 7 and B; Table 4) and specific growth rate
(SGR) (Table 5). There was no statistical difference observed in growth between
glucan treated and non-treated fish.
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Figure 7. Changes in weight (g) at various times in Arctic charr (S. A/pinus)
following treabnent by immersion in glucan at Omgl\... (----L...- ), 1mgIL
(----+----) or 10mgIL (- ..•.... ). Vertical bars are standard error of mean. N=10
for each group.
4S
220 _
200 _
S 180_
.,
.2'
; 160-
~
~ 140-
120
.-
,/,.-:.,
" .'
" .'
" .',-~.. ,
100 "'--- _
o 30 56
Days after treatment
78
Figure 8. Changes in weight (9) at vanous times in Arctic charr (S. a/pinus)
following treatment by injection with glucan at Omglkg ( ·-----);-.mglkg
.·_····+or 10rnglkg ( ). Vertical bars are standard error of mean.
N=10 for each group.
Table 4. Changes In weight and length of Arctic charr following treatment by glucan Injection with 1 and 10
mglkg or immersion in 1 and 10 mg/L. .. Indicates measurements taken from only one fish due to loss of
identification tags.
Method of Average weight (g) Average length (em)
administration Do.e
Day 0 Day 30 Day 58 Day 78 Day 0 Day 78
In]aotian Omglkg 111.5± 12.93 143.2 ± 13.88 171.0 ± 25.64 203.9 ±18.36 19.8 ± 0.95 23.1 ± 1.25
1mglkg 106.7 ± 13.77 139.2 ± 21.87 157.5 • 181.9 • 19.8 ± 1.01 22.5 •
10mg/kg 120.7 ± 11.87 150.4 ± 38.22 178.2 ± 29.67 200.2 ± 5.06 20.5 ± 0.69 23.8 ± 1.57
Immersion Omg/L 114.4 ± 17.14 153.6 ± 28.44 196.4 ± 42.62 227.4 ± 7.77 19.7 ± 1.48 23.8 ± 2.25
1mgIL 110.6 ±17.37 140.5 ± 30.50 193.1 ± 30.69 208.6 +28.28 19.6 ± 0.90 23.3 ± 1.06
10mg/L 114.0± 15.22 152.5 ± 18.50 178.5 ± 28.65 188.2±7.14 19.9 ± 0.94 23.5 ± 1.32
;;
Table 5. Specific growth rates of Arctic charr following treatment by grucan
injection with 1 and 10 mglkg or immersion in 1 and 10 mgIL
.,
Method of Specific growth rate (SGR)
administration 0-
0.y3O Ooy56 Day 78
Injection Omglkg 0.84 0.69 0.80
1mglkg 0.89 0.48 0.65
10mglkg 0.73 0.65 0.33
Immersion OmgIL 0.98 0.95 0.66
1mgIL 0.80 1.22 0.31
10mgIL 0.97 0.56 0.29
".
3.3 EFFECT OF GLUCAN ON DISEASE RESISTANCE
3.3.1 Growth characteristics of Yers;nia ruckeri
Y. rockeri exhibited Iogarithmk: growth between 6-12 hours after inoculation into
fresh medium (Figure 9). Therefore, bacterial cultures at nine hours after
inoculation were used for challenge.
3.3.2 Concentration of bacterial a.pension
Cultures of V. rockeri in the mid phase of growth were harvested and diluted
to determine concentration. Bacterial concentration was 2.4x1010 Colony
Forming Units (CFU)lmJ. This was diluted to make concentrations for dose
determination in challenge experiments.
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Figu~ 9. Growth curve showing the logarithmic phase of growth of Y. ruckeri.
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3.3.3 Route and dose of infection
To determine the effect of glucan on disease resistance in Arctic charr, fish
were challenged with Y. ruckeri. Prior to infection, the concentration and
appropriate route of infection resulting in moderate mortalities were determined.
It was observed that infection by immersion in Y. ruckeri suspension did not
induce mortality. Injection of fish with either 2.4)( 109 and 2.4 x 10'0 CFUlfish
resulted in mortalities on Day 1 and on Days 1 and 2 respectively (Table 6).
Injection with 2.4)( 107 CFU/fish was found to be the most effective dose for
infection because it induced evenly spread mortalites over five days and was
therefore used as the route and concentration of bacterial infection of fish in
challenge in section 2.8.5.
Table 6. Infection in Arctic charr (5. a/pinus) with Yersinia rocken".
• Indicates the most appropriate route and dose of infection.
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Total
Method of No. of mortalities on days mortlility
administration CFU/mllfish after challenge (/10)
1 2 3 4 5
Injection 2.4)( 10 0 0 0 0 0 0
2.4 X 107 1 0 2 0 1 4"
2.4 x 10' 2 4 0 0 0 6
2.4)( 10i 8 0 0 0 0 8
Imme~ion 2.4 x 10 0 0 0 0 0 0
2.4)( 10' 0 0 0 0 0 0
"3.3.... R..istance to infection
For determination of the effect of glucan on disease resistance. fish were
treated with gluesn and challenged with Y. ruckeri on Days 1, 7 and 14 after
treatment Mortalities were recorded twice daily. All dead and severely
moribund fish were counted and collected for internal and external examination.
Fish that died from jumping out of their tanks onto the floor were excluded in the
mortality counts and initial numbers, since it was assumed they did not die from
experimental infection.
Fish were monitored for at least three weeks. except for those challenged
on Day 7 after glucan treatment. This was because all the fish in the control for
this group died due to mechanical problems. Mortalities in the Day 7 glucan
treated group were monitored for 20 days. However, only the first five days
were taken into account in calculating % mortality and Relative Percent
Protection (RPP) for these groups.
In all groups, there was no mortality observed on the day of challenge (Day
0). The earliest mortalities recorded were a day after challenge in both the
treatment group challenged on Day 7 after immersion in glucan, and the non-
treated control for fish challenged on Day 14 after immersion in grucan.
Infection was typified by severe congestion and petechial haemorrhage on the
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head and by flaccid. inflamed intestines containing mucus, combined with
S'Nelling of internal organs.
The haemorrhage was especially obvious around the edge of the eye where
a red ring was observed. Application of pressure on the abdomen produced a
discharge of blood-stained mucous from the anus. The region around the
mouth. especially the lower jaw, and the region between the mouth and the
base of pectoral fins was also blood stained. In some cases, this condition was
extended to the gills and base of the pectoral and ventral fins. Internally, the
stomach was virtually empty except for blood-stained mucous. In severe cases,
most internal organs such as kidney, liver, and spleen were dark and appeared
to be swollen. Most of the other organs were covered with a thick layer of the
blood·stained mucous.
Bacteria obtained from the infected fish showed yellowish-befge colonies
which had glistening surfaces. The colonies were 1-1.5 mm in diameter and
characterized by convex e~vations. entire margins and a butter-like
consistency. Isolates were gram-negative and were shaped as straight, short
rods without spores. Identification by API 2a~ biochemical system confirmed
the presence of Y. rocl<eri.
Cumulative mortality was highest in the Day 14 non-treated control and
lowest in the Day 14 treatment group (Table 7). Treatment by immersion in
1mgIL of glucan suspension on 1 and 1 days before challenge resulted in higher,
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but not statistically significant percent mortalities (P>O.OS). Relative Percent
Protection (RPP) was highest in the group that was challenged 14 days after
glucan treabnent, an indication that glucan treatment 14 days in advance of
infection was more effective than treabTlent on 1 and 7 days prior to infection.
Chi-square el> tests used to compare survival of glucan-treated fish against
non·treated controls showed that treatment with glucan 14 days prior to infection
resulted in a significant increase in survival (P<O.OS).
Tlble 7. Mortality (%) and Relative Percent Protection (RPP) offish challenged 1. 7 and 14 days
after treatment with gluean.• IndIcates significant x2 distribution probability value (P<O.05).
No. of daya from No. of fish per Relative Percent
Immersion treatment group Totol mor1aIlUa. Mor1allty (%1 Protection
to challenge {gluclnlconlroll (glucln/controll (glueen/control) (RPPI P value
1 64/65 28/27 43.8/41.5 -5.3 0.79
7 701/6 27/29 36.6/38.2 -1.1 0.95
14 69/62 21/29 30.4/48.8 34.9 0.05'
CHAPTER 4 • DISCUSSION
4.1 ACTIVATION OF NEUTROPHILS
Administration of some immunstimulants has been reported to increase the
resistance of fish to microbial infection. This has been attributed to enhanced
non-specific defences, particularty the phagocyte system. This study has
demonstrated the ability of fi-glucans to enhance non-specific defences of Arctic
charr.
Activated neutrophils were recognized by their ability to stain dark blue with
Nitro Blue Tetrazolium (NBT). Maximum neutrophil activation was observed on
Day 14 following glucan administration by immersion in 1mgIL of glucan
suspension.
Neutrophils of fish injected with glucan did not exhibit significant activation.
This may be related 10 stress induced by handling of fish during injection and by
anaesthesia. Un-neutralized MS-222. the anaesthetic used in this study, has
been found to induce metabolic disturbances which, when combined with stress,
may cause suppression of neutrophils. It also causes blood chemistry changes.
which are attributed to the low pK of MS-222 (Black and Connor. 1964;
Wedemeyer. 1970; Pickering, 1993).
Studies with other fish species have shown that activation of circulatory
neutrophils may be achieved by application of certain immunostimulants such as
Levamisole, auatemary Ammonium Compound (CAC) and short-dlain
polypeptides (Anderson and Jeney. 1992; Jeney and Anderson, 1993). In these
studies, relatively low doses of about 5 J.lg per fish have been found effective;
with much higher or lower doses having adverse effects such as increased
mortality (Robertsen et al.. 1990a).
Although the precise mechanisms involved in grucan induced neutrophilia in
fish are not well understood. in mammals they have been associated with
enhanced production of Colony Stimulating Activity (CSA), which resutts in
increased production, recruitment, and/or release of neutrophils (Williams et al..
1988). Neutrophils have been associated with tissue damage through
production of Reactive Oxygen Species (ROS) such as O£. HzOz, and OH,
which are toxic to pathogens entering the hosfs body and play an important role
in their destruction (Chung and Secombes, 1967).
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4.2 ACTIVATION OF MACROPHAGES
RSh maaophages have a wide range of functions induding phagocytosis.
presentation of antigens, release of antimicrobicidaJ and antitumour agents, and
production of cytokines (MacArthur and Fletcher, 1985; Namaware et al..
1994). Activity of these cells can be modulated to increase immunocompetence
( Pulsford et aI., 1994). The biochemical pathways involved in microbicidal
activtty of macrophages are not well known. but are dependent on two
mechanisms; an oxygen dependent system which involves production of
Reactive Oxygen Species (ROS) and an oxygen independent system.
Macrophage activation can be achieved directly by soluble fadors such as plant
lectins and bacterial cell wall proteins as well as by Iymphokines secreted from
antigen or mitogen stimulated T-Iymphocytes (Chung and Secombes, 1987).
Macrophage activation was monitored by Phagocytic Ratio (PR) and by
Phagocytic Index (PI). PR is a percentage of phagocytic ce{ls and is a less
sensitive measure than PI, which is a measure of the number of engulfed
particles (yeast cells in this case) by each macrophage (Namaware et al.•
1994). PR was enhanced on Days 2-14 by immersion in 10 mgll of glucan
suspension, with 41.5% of the cells ingesting ingest yeast ceUs. This ratio is
relatively low compared to 78-97 % phagocytosis obtained by Namaware et al.
"(1994). It is possible that this low phagocytic ratio may be related to the stress
induced by handling and anaesthesia.
PI values were also increased by on Days 2-14 by immersion in 10mg/L and
were in general agreement with those obtained by Namaware et aL, (1994),
who obtained values between 1.8 and 4.2. Therefore. we concluded that
immersion in 10mglL was the most effective treatment for stimulation of
phagocytic activity of macrophages in Arctic charr. Inability of the injection
method to increase the phagocytic activity of Arctic charr macrophages in this
study further emphasizes it's stressful nature.
Increased activation between Days 2-14 may be explained by reduced levels
of glucan particles during this period, therefore facilitating phagocytosis
(Robertsen et aI., 1990a). In the period between Days 21-35, gluca" levers
may have become reduced to sub-optimal levels for significant stimulation of
macrophages.
This study has revealed that high doses of glucan (10 mglL) activated
macrophages while lower levels were more effective in neutrophil activation.
This may be because macrophages are larger and can ingest more glucan
particles than neutrophils. In plaice, Pleuronectes plafessa, for example,
macrophages have a diameter of 12-20J.1rn compared to 8-10J.1m for neutTophils
(Ellis, 1976).
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Effects of fJ-glucans on host defences have attraded much attention and
have been investigated by several authors in various cultured fish species (Vane
and Mangidaan, 1989; Yana et aI., 1989, 1991; Chen and Ainsworth. 1992;
Engstad et aI., 1992; Matsuyama et al.. 1992; Brattgjerd et aI., 1994; Jeney
and Anderson. 1993; Engstad. 1994; Efthimiou, 1996). The stimulatory effect
of glucan on disease resistance is associated with their structure and is believed
to have developed early in the evolution of plants and animals as a mechanism
for defence against fungal pathogens.
Glucan is a polysaccharride made up of glucose units (Sectionl.5). The way
these glucose units are linked. and the number and length of side branches,
are important (Onarheim, 1992). The side chains are recognized by
macrophage receptors which they stimulate, thus triggering a series of
microbicidal activities in preparation for ingestion of the glucan particles
(Mitchell, 1992). Therefore. treabnent of fish with yeast glucan prepares their
non-specific defences in readiness to fight against potentially dangerous micro-
organisms (Efthimiou, 1996; Engstad and Robertsen, 1993. Engstad et al.,
1993).
'I
4.3 EFFECT ON GROWTH
Arctic charr treated with gluca" did not show evidence of an increased or
inhibitory growth etrect.. This observation is similar to that of other studies in
which gluca" did not stimulate growth. Juvenile dentex (Dentex dentex) did not
increase growth when fed with glucan--tncorporated diets (Efthimiou, 1996), and
studies with Rainbow trout (Oncorhynchus mykiss) also showed lack of
increased growth following gluca" treatment (Matsuo and Miyazono, 1993).
However, several other immunostimulants have shown an ability to increase
growth. Levamisole, a levo--isomer of tetramisole and is used as a drug for
treating helminth infections in ruminants. has been found to be an effective
growth stimulant for carp (Cyprinus carpio) larvae. This has been attributed to
stimulation of metabolism, thus increasing immune functions (Siwicki and
KossakowsJO, 1988). Immuno-stimulation of Tiger shrimp (Penaeus monodon)
with gluca" has been shown to be effective in enhandng their growth (Sung et
al.. 1994).
It appears, therefore, that results obtained on the effects of glucan on
growth are inconsistent. However, it should be noted that effects may be
compromised by acute fonns of handling stress, such as those associated with
the routine procedures of grading, transportation and artificial stripping. These
result in physiological stress responses and an elevation of plasma
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catecholamines and corticosteroids coupled with changes in osmotic and ionic
regulation. Chronic stresses associated with intensive fish farming include such
phenomena as deterioration of water quality and the less obvious but equally
important stresses of social dominance. with submissive fish showing enhanced
interrenal activity, increased susceptibility to infections and reduced growth
(Pickering, 1981; 1993; Pickering et al.• 1982; Pulsford et aI., 1994).
4.4 RESISTANCE TO INFECTION
The results of the present study have demonstrated the ability of yeast
glucan to induce protection in Arctic charr against Enteric Redmouth (ERM)
disease. Fish treated with glucan by immersion in 1mgIL of glucan suspension
and challenged by injection with Y. ruckeri, the aetiological agent for ERM.
showed significant. increased resistance.
Artificial infection of Arctic charr with Y. ruckeri resulted in internal and
external clinical signs similar to those described by Newman and Majnarich
(1982) and Bullock and Slucl<ey (1976).
Fish that were chaltenged 14 days after treatment with glucan displayed the
highest survival. This is in general agreement with other studies (Robertsen et
al., 1990a; Vano et aI., 1991, 1992; Anderson and Siwicki, 1994; Sung et aI.,
1994), and confinns the ability of yeast glucan to induce protection from disease
OJ
infection in Arctic charr. Resistance to Y. rockeri infection after glucan treatment
followed similar kinetics as those for neutrophil and macrophage activation.
where maximum activation was obsefved on Day 14 after glucan treatment.
Therefore, neutrophils and maaophages parUy explain the mechanism by which
gluca" induces protection in Arctic charT. Stimulation of non-specific defences
can thus be timed in anticipation of infection, especially when fish are expected
to become exposed to a specific pathogen at a particular time such as before
transfer from hatchery to culture facilities (Anderson and Siwicki, 1994).
13-glucans have been shown to increase the survival of carp, Cyprinus
carpio, from Edwardsiella tarda and Aeromonas hydrophi/la infections at
concentrations of 2-10 and 5 mglkg respectively when given by intraperitoneal
injection (Vane at al.. 1989; 1991). This increased survival was due to the
activation of the Alternative Complement Pathway (ACP). Chen and Ainsworth
(1992) have demonstrated the ability of 1.\-1,3 glucans to reduce mortality as a
result of experimental infection with Edwardsiella ictaJuri in Channel catfish.
Ictalurus punctatus, and have shown the important role played by these
substances in stimulating protective responses against bacterial infection. They
found that concentrations of 0.5 mglkg were effective in conferring protection
against infection at lower bacterial concentrations, while higher doses were
required for higher bacterial concentrations.
Treatment of Brook trout. SaJve/inus fontinalis, with a grucan extrad from
barley by single injections of 1 mgJkg or 3Q-minute immersions in 1000 mgIl.
resulted in high protection levels against infection with Aeromonas salmonicida,
with injection giving more protection than immersion. Protection was induced in
the injected group earlier than in the immersed. and had diminished in both
injected and immersed fish 14 days after imrnuno-stimulation (Anderson and
Siwicki. 1994).
Glucan has also been administered in the form of a teed component and has
been found to increase protection of fish from disease infection. Peptidoglycan,
a type of glucan which is derived from the bacterium. Bifidobacterium
thermophilum, when fed to Rainbow trout at 6 j.1g/kg per day for 56 days
resulted in increased survival after infection with Vibrio anguillarium. This
increase diminished by day 56. suggesting negative impacts on disease
resistance by prolonged oral administration ( Matsuo and Miyazono, 1993).
Studies have shown that feeding of glucan above a certain threshold does not
improve the stimulatory effects (Onarheim,1992). Chinook salmon
(Oncorhynchus tswaytscha ) when ted on diets containing a type of ti- glucan.
VJtaStim-Taito (VST), at rates of 0.1 and 1.0%, showed increased protection
from A. salmonicida infection (Nikl et al.. 1993). On the other hand, LaJl and
Olivier (1995) have found that incorporation of glucan in diets yields inconsistent
levels of protection.
"It seems that glucan can enhance protection against diseases within only
certain concentration ranges. Sung et al. (1994) observed that immersion in high
glucan concentrations (2000 mg/L) causes adverse gill tissue effects while
concentrations of 500 and 1000 mgIL increase protection from infection by Vibrio
vulnmcus in r'ger shrimp. Robertsen et al. (1990a) suggested that injection at
concentrations as high as 100rnglkg may cause adverse effects such as
increased mortality.
The ability of glucan to enhance disease resistance in Att:tic charr is related
to its effect on non-specific defences. namely activation of neutrophils and
macrophages. The results of this study have demonstrated that maximum
activation of these cells correlates with the day that showed the highest survival.
The time and duration of protection depends on concentration and route of
administration. High doses take a longer time to achieve protection than lower
ones. probably because of overloading of phagocytic cells with glucan particles.
It has been shown that 3-4 weeks are required to achieve maximal protection
with 100 mglkg (Robertsen et aI., 1990a) and one week with 2-10 mglkg
(Matsuyama et at, 1992). In general, injection at concentrations of 0.5-10
mg/kg have been found to be effective at inducing protection, which lasts about
7-14 days (Vano et aI., 1989, 1991; Chen and Ainsworth, 1992) while
immersion in gluesn suspensions of 500-1000 mgIL produce protection for
about 14-18 days (Anderson and Siwidti, 1994; Sung et aI., 1994).
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Nonetheless, other factors such as the type of pathogen in the environment may
contribute to determining the route of administration to be used. In cases where
the disease is associated with skin damage. for example. immersion may be a
better method of application (Efthimiou, 1996).
Most documented work on glucan has been based on artificially induced
diseases in laboratory settings. However. ifs effects on natural outbreaks have
been observed recently in juvenile dentex. Dentex dentex. It was observed that
glucan treated fish developed resistance to a protozoan infection (Efthimiou,
1996), thus showing the ability of the substance to enhance protection during
natural epizootic infections.
VVhilst the effectiveness of glucan at increasing protection against disease is
well documented. some studies have reported increased mortality following
administration. According to Robertsen et aL (1990a), this may be due to
phagocytic overloading, with high concentrations of g[ucan particles lowering
phagocytic activity. High concentrations of other types of immunostimulants
have shown the same effect (Robertsen et at, 1990b).
The inability of glucan to induce protection has also been documented. Nikl
et aL (1993) demonstrated that Chinook salmon Oncorhynchus tshawytscha
immersed in VItaStim-Taito (VST), a commercial type ofglucan, failed to yield a
significant amount of protection. It was suggested that VST was not readily
taken up through this route.
"It has been shown that activated macrophages produced after glucan
treatment may be responsible for increased antibacterial defences (Robertsen et
al.. 1990b). Vane et al. (1989) have shown that polysaccharrides derived from
fungi such as Schizophylfum commune, Sclerotium glucanium and Lentinus
edodes are able to induce increased survival and to reduce bacterial numbers in
the blood of polysaccharride-treated carp (Cyprinus carpio). They attribute these
activities to an increased phagocytic activity of carp pronephros cells induced by
treatment with the potysaccharTides.
Appearance of macrophages in the peritoneum and presence of glucan
particles in peritoneal macrophages after intraperitoneal injection of yeast
gluesn in Atlantic salmon further supports the idea that macrophages are the
target cell for glucan action in fish and other vertebrates (Jorgensen et aI.,
1993).
It has been shown that glucans mediate their effect by activating a number of
non-specific defence mechanisms such as increased production of lysozyme.
Another possible mechanism is through the Alternative Complement Pathway
(ACP), which has been described as partly responsible for increased protective
effects of 1,6-branched -~1,3-gJucans (Vano et aI., 1991).
6.
CHAPTER 5 - CONCLUSION
The effects of jJ-glucan derived from yeast cells, S. cerevisiae on the non-
specific defences and resistance to ERM disease in Arctic charr (Salvelinus
a/pinus) have been illustrated by the present study.
Neutrophil activation was monitored by the Nitro Blue Tetrazolium (Nan
assay and was highest at Day 14 following glucan treatment Gluca"
administration by immersion was found to be more effective at stimulating
neutrophil activation than when given by injection. Lower doses of 1mglL had
the greatest stimulatory effect.
Phagocytic activity was monitored by PR and PI and were increased by
immersion in 10mgIL of gluca" suspension between Days 2-14 after gluca"
treatment. Therefore, of the two methods that were used in this study,
immersion at 10mgIL was more effective in elevating phagocytic activity of
macrophages in Arctic chaIT.
Glucan did not affect the growth of Arctic charT. Survival of Arctic charr
infected with Y. ruckeri showed that treatment by immersion in 1mgIL of glucan
suspension at 14 days before infection increases survival.
"RECOMMENDATIONS
From the observations on neutrophil and macrophage activation. this study
has established that duration of this activation lasts for about 14 days, after
which it dedines. Therefore, it is recommended that booster doses should be
given every 14 days. Multiple doses may be more effective at producing
prolonged protection against natural outbreaks of microbial infections. However,
since the prolonged effects by injection or immersion are not well understood,
their long-term effect requires investigation.
Oral administration of glucan as a feed component may be a better
alternative to administration of multiple doses by injection or immersion as it is
less stressful and time consuming. Onarheim (1992) has suggested that fish
should be on fed gluca" diets for two weeks followed by six weeks of regular
feeding since prolonged feeding with glucan diets causes immuno-suppression.
However. a major disadvantage to this mode of administration is that fish must
regularty feed on the glucan diets for immuno-stimulation to occur. Oral
administration woukj therefore be of limited use, especially in sick fish whose
appetite is usually diminished. In healthy fish, it: provides a more attractive
method of administration
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Introduction of new culture species for warm and cold water cufture is a
major consideration in the aquacutture industry. The effect of glucans in some
warm water aquaculture species sud1 as Common carp (C. carpio) (Yana and
Mangindaan, 1989) and Trger shrimp (P. monodon), (Sung et al., 1994) have
been studied. However, there has been no work done on some of the other
cold water species of growing economic interest to Atlantic Canada's
aquaculture industry, including Winter flounder (Pleuronectes americanus),
Yellowtail flounder (Pfeuronectes ferruginea), Atlantic halibut (Hippoglossus
hippoglossus) and Wofffish (AnarlJichas spp.) (Brown et aI., 1995). Similar
studies in these species woukt help to develop effective disease control
programs for increased production in the region.
Currently, the centre of focus is on the effect of gtucan on the development
of resistance to artificially induced diseases (Efthimiou, 1996). There is also a
need to study the effect of glucan on resistance to subclinical diseases and
natural disease outbreaks.
The effect of gtucan on growth is inconsistent and requires further
investigation. Nonetheless, growth indices provide safety measures in glucan
application schedules.
Glucan's ability to increase resistance provides a suitable prophylactic tool
for controlling opportunistic infections which are notorious for manifesting
themselves during stressful conditions, such as those induced by handling
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during prophylactic treatment grading, transportation. and in sutKlptimal
environments (Efthimiuo. 1996). Treatment with glucan prior to transfer to new
environments can also boost non-specific defences in preparation for the
unknown. Under culture. it can be used regularly to keep the non-specific
defences alert in case of an outbreak, which would help to reduce loses before
specialized forms of treatment, if required. are given.
Treatment with glucan holds promise to an effective, environmentalty
acceptable, and cost effective tool for control of infectious diseases. It is likely
to be the method of choice in the near future for the aquaculture industry in
AtJantic Canada, as well as other parts of the world.
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Appendix A: One--way analysis of variance (ANOVA) for neutrophil
activation by gluCiln treatment.
Day 0
1mglkg 10mgikg Omglkg lmgIL 10mgIL OmgIL
0.333 0.167 0.667 0.500 0.833 1.167
0.667 0.667 0.167 0.833 0.500 0.833
0.333 0.500 0.667 0.667 1.000 0.667
0.667 1.000 0.333 1.000 0.167 0.667
0.167 1.000 0.500 0.333 0.000 2.000
Anova: Single Factor
SUMMARY
Groups Count Sum Avetage Variance
Column 1 5 2.167 0.433 0.050
Column 2 5 3.333 0.667 0.125
Column 3 5 2.333 0.467 0.047
Column 4 5 3.333 0.667 0.069
Column 5 5 2.500 0.500 0.181
Column 6 5 5.333 1.067 0.314
ANOVA
Source of 55 df M5 F P-vaJue Ferit
Vanation
Between Groups 1.378 5 0.276 2.1032 0.1 2.621
WrthinGroups 3.144 24 0.131
Total 4.522 29
Appendix A (Cont'd)
Day 1.
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1mglkg
1.333
1.333
0.667
0.500
0.500
10mgJ1<9
1.667
1.333
1.667
2.333
1.667
Omgil<9
0.833
0.500
0.833
0.500
0.667
lmgJL
1.667
2.833
•.333
•.333
3.000
10mgIL
2.167
2.000
0.833
1.333
0.833
OmgIL
1.000
1.167
1.167
0.667
0.833
Anova: Single Factor
SUMMARY
Groups Count Sum Average Variance
Column 1 5
Column 2 5
Column 3 5
Column 4 5
Column 5 5
Column 6 5
•.333
8.667
3.333
16.167
7.167
•.833
0.867 0.186
1.733 0.133
0.667 0.028
3.233 1.272
1.•33 0.397
0.967 0.047
ANOVA
Source of S5 <if MS F P-value Fcrit
Variation
Between Groups 22208 5 ....2 12.913 4E-Q6 2.621
Within Groups 8.256 24 0.344
Total 30._ 29
Appendix A (Cont'd)
Day 28
1"'9'1<9 10mglkg Omglkg 1mgIL 10mgIL OmglL
2.167 2.167 1.167 0.667 0.833 1.667
0.833 0.833 0.333 0.667 0.833 1.000
0.500 0.500 0.167 2.333 1.000 0.333
0.167 0.167 0.667 1.167 0.667 0.667
0.333 0.333 0.167 0.833 1.000 0.667
Anava: Single Factor
SUMMARY
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Groups Count
Column 1 5
Column 2 5
Column 3 5
Column 4 5
Column 5 5
Column 6 5
Sum
4.000
4.000
2.500
5.667
4.333
4.333
Average Variance
0.800 0.644
0.800 0.644
0.500 0.181
1.133 0.492
0.867 0.019
0.867 0.256
ANOVA
Source of 55 df MS F P-vaJue Fetit
Van'sOOn
Between Groups 1.027 5 0.205 0.5511 0.736 2.621
WrthinGroups 8.944 24 0.373
Total 9.971 29
Appendix B: On-.way analysis of variance (ANOVA) for phagocytic index
by gluea" treatment
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1mglkg
~
13.3
0.495
1.25
Anava: Single Factor
SUMMARY
~
0.7475
0.33
0.325
Groups
Column 1
Column 2
Count Sum Avetage Variance
15.045 5.015 51.623
1.4025 0.4675 o.ossa
ANOVA
Source of SS df MS F P-value Ferit
Variation
Between Groups 31.02 1 31.02 1.2004 0.3348 7.7086
Wrthin Groups 103.38 4 25.841
Total 134.38
Appendix B (Confd)
10 mglkg
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~
4.03
1.12
10.458
~
0.35
0.325
0.49
Anava: Single Fador
SUMMARY
Groups
Column 1
Column 2
Count Sum Average Variance
3 15.608 5.2025 22.828
3 1.165 0.3883 0.0079
ANOVA
Source of 55 df M5 F P·value Ferit
Variation
Between Groups 34.764 1 34.764 3.0447 0.1559 7.7086
Within Groups 45.672 4 11.418
Total 80.437
Appendix B (Cont'd)
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Omglkg
~
3.255
1.275
1.815
~
0.455
2.025
1.44
Anava: Single Factor
SUMMARY
Groups
Column 1
Column 2
ANOVA
Count Sum
3 6.345
3 3.92
Average
2.115
1.3067
Variance
1.0476
0.6296
Source of 55 df
Variation
Between Groups 0.9801
Within Groups 3.3543
MS
0.9801
0.8386
F P-vafue Fcrit
1.1688 0.3405 7.7086
Total 4.3344
Appendix B (Conrd)
"
1mgIL
llal<..2:H
6.825
1.76
2.9375
~
1.575
2.25
1.15
Anava: Single Factor
SUMMARY
Groups
Column 1
Column 2
Count Sum Average Variance
11.523 3.8408 7.0256
4.975 1.6583 0.30n
ANOVA
Source 0' 55 df M5 F P-value Fcrit
Variation
Between Groups 7.'45 , 7.145 1.9466 0.2352 7.7086
Within Groups 14.667 4 3.6666
Total 21.812
Appendix C: One..way analysis of variance (ANOVA) for phagocytic ratio
by glucan treatment
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1mglkg
~
47.5
9
12.5
~
11.5
6
6.5
Anova: Single Fador
SUMMARY
Groups
Column 1
Column 2
Count Sum Average Variance
3 69 23 453.25
3 24 8 9.25
ANQVA
Sourceo! 55 df M5 F P-value Fcrit
Variation
Between Groups 337.5 337.5 1.4595 02936 7.7086
Within Groups 925 231.25
Total 1262.5
Appendix C (Confd)
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10mglkg
~
26
16
44.5
~
7
6.5
7
Anava: Single Factor
SUMMARY
Groups
Column 1
Column 2
Count Sum Average Variance
3 86.5 28.833 209.08
3 20.5 6.8333 0.0833
ANOVA
Sourr:eof 55 elf MS F P-value Fcrit
Variation
Between Groups 726 1 726 6.9418 0.0579 7.7086
Within Groups 418.33 4 104.58
Total 1144.3
Appendix C (Confd)
Omglkg
~
21
15
16.5
Anova: Single Factor
SUMMARY
Groups
Column 1
Column 2
~
7
15
12
Count Sum
3 52.5
3 34
Average Variance
17.5 9.75
11.333 16.333
.8
ANQVA
Source of Variation 55 df M5 F p- Feri!
value
Between Groups 57.042 57.042 4.3738 0.1047 7.7086
Within Groups 52.167 13.042
Total 109.21
Appendix C (Cont'd)
1 mgIL
Ila2=1i
32.5
16
23.5
Anava: Single Factor
SUMMARY
Groups
Column 1
Column 2
ANOVA
~
17.5
15
11.5
Count Sum Average Variance
3 72 24 68.25
3 44 14.667 9.0833
..
Source of Variation
Between Groups
Within Groups
Total
55 df
130.67 1
154.67 4
285.33
MS F P-value
130.67 3.3793 0.1399
38.667
Fcrit
7.7086
Appendix C (Conrd)
10mgIL
Day 2-14
41
40.5
43
Anava: Single Factor
SUMMARY
Groups
Column 1
Column 2
ANOVA
Day 21-35
19
7.5
6
Count Sum Average Variance
3 124.5 41.5 1.75
3 32.5 10.833 50.583
100
Source of Variation
Between Groups
Within Groups
Total
55
1410.7
104.87
1515.3
df MS F P-vaJue F em
1 1410.7 53.911 0.0018 7.7086
4 26.167
Appendix C (Cont'd)
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OmgIL
~
15
35
13.5
~
16
10
9.5
Anava: Single Factor
SUMMARY
Groups
Column 1
Column 2
M/OVA
Count Sum Average Variance
3 63.5 21.167 144.06
3 35.5 11.833 13.083
Source of Variation
Between Groups
Wrthin Groups
Total
55 df
130.67 1
314.33 4
445
M5
130.67
78.583
F
1.6628
P-value
0.2667
Ferit
7.7086
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Appendix 0: One-wllY analysis of variance (ANOVA) for weights by glucan
treatment.
DoyO
lmg1kg
115.8
114.3
106.4
113.5
100.4
134.2
105.4
100.3
87.0
89.6
10mglkg Omglkg
115.8 112.4
123.6 103.6
108.5 108.5
108.5 123.2
133.9 103.7
141.4 110.8
132.5 143.4
109.8 102.8
117.1 101.9
116.0 104.4
lmgIL
113.3
130.0
117.0
101.8
143.2
103.6
102.4
117.8
88.7
88.2
10mgIL OmgIL
121.7 123.3
114.1 109.1
102.6 106.9
102.9 138.8
114.3 145.1
141.9 117.1
130.2 95.2
120.4 101.3
99.0 112.9
92.4 94.6
Anava: Single Factor
SUMMARY
Groups
Column 1
Column 2
Column 3
Column 4
Column 5
Column 6
COunt
10
10
10
10
10
10
Sum Average Variance
1066.9 106.69 189.55
1207.1 120.71 136.21
1114.7 111.47 167.37
1106 110.60 301.58
1139.5 113.95 231.77
1144.3 114.43 293.69
ANOVA
Source of S5 df M5 F P-value Ferit
Variation
Between Groups 1103 5 220.61 1.003 0.425 2.386
Within Groups 11882 54 220.03
Total 12985 59
Appendix 0 (Cont'd)
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lmgJkg
134.9
163.3
151.5
157.1
117.5
110.8
10mglkg
93.8
136.7
174.3
216.0
161.8
149.8
161.5
109.1
Omgikg 1mgIL
145.5 129.9
131.5 135.5
163.5 207.4
128.9 144.9
146.8 123.2
154.4
111.8
116.8
lOmgIL OmgIL
142.6 124.2
176.2 200.6
157.2 165.0
133.9 124.7
151.8
155.5
Anava: Single Factor
SUMMARY
Groups
Column 1
Column 2
Column 3
CoJumn4
Column 5
Column 6
Count
6
8
5
8
4
6
Sum
835.1
1203
716.2
1123.9
609.9
921.8
Average
139.18
150.38
143.24
140.49
152.48
153.63
Variance
469.69
1460.7
192.93
930.03
342.58
809.07
ANOVA
Source of SS df MS F P-valu8 Fcrit
Variation
Between Groups 1228.7 5 245.75 0.306 0.906 2.523
'VVithin Groups 24929 31 804.15
Total 26157 36
Appendix 0 (Conrd)
Day 56
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1mglkg
157.5
10mglkg
135.4
194.4
190.3
2112
206.3
148.7
161.1
Omglkg 1mgIL
173.7 199.1
206.3 220.4
151.5 159.9
152.6
10mgIL OmgIL
163.5 147.3
203.4 264.5
193.5 185.4
145.7 198.2
186.8
Anava: Single Factor
SUMMARY
Groups Count Sum Average Variance
Column 1 1 157.5 157.50
Column 2 7 1247.4 178.20 880.3
Column 3 4 684.1 171.03 657.4
Column 4 3 579.4 193.13 941.8
Column 5 4 706.1 176.53 710.1
Column 6 5 982.2 196.44 18162
ANOVA
Source of SS df MS F P-value Fcrit
Variation
Between Groups 2712.1 5 542.43 0.527 0.753 2.773
Within Groups '8533 18 1029.6
Total 21245 23
Appendix 0 (Confd)
0.y78
lOS
lmgJk9
181.9
10mgJk9
156.0
222.9
242.5
232.5
147.1
OmgJk9 lmg1l.
216.9 226.6
222.4 186.6
186.7
189.6
10mgll. OmgIL
202.0 170.2
205.6 299.0
156.9 217.3
242.8
207.6
Anava: Single Fador
SUMMARY
Groups Count Sum Average Variance
Column 1 1 181.9 181.90
Column 2 5 1001 200.20 2030.3
Column 3 4 815.6 203.90 337.19
Column 4 2 413.2 206.60 800.00
COlumn 5 3 564.5 188.17 736.44
Column 6 5 1136.9 227.38 2282.4
ANOVA
Source of SS df MS F P-value Fcrit
Variation
Between Groups 4004.6 5 800.9 0.546 0.739 2.958
Within Groups 20535 14 1486.8
Total 2454ll 19
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Appendix E: One-way analysis of variance (ANOYA) for lengths by glucan
treatment.
lloyO
lmgJkg 10mglkg OmgJkg lmgIL 10mg1L OmgIL
20.0 20.0 19.0 19.0 19.5 20.5
19.0 20.5 19.0 20.5 20.0 20.0
20.5 19.5 18.5 19.5 19.0 19.5
20.0 20.0 21.0 19.0 19.5 21.5
19.5 20.5 20.0 21.5 20.5 21.0
21.0 22.0 19.5 19.5 21.5 20.0
20.0 21.0 21.5 18.5 21.0 16.5
21.0 20.0 19.5 20.0 20.0 19.5
18.0 20.5 20.5 19.0 19.0 20.0
18.5 20.5 19.5 19.0 18.5 18.0
Anava: SingJe Fador
SUMMARY
Groups
Column 1
Column 2
Column 3
Column 4
Column 5
Column 6
Count
10
10
10
10
10
10
Sum
197.5
204.5
198.0
195.5
198.5
196.5
Average Variance
19.75 1.0139
20.45 0.4694
19.80 0.9000
19.55 0.8028
19.85 0.8917
19.65 2.1139
ANOVA
Source of SS df MS F P-value Fcrit
Variation
Between Groups 5.021 5 1.004 0.973 0.443 2.386
Within Groups 55.725 54 1.032
Total 60.746 59
Appendix E (Confd)
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Cay 78
lmg11<9
22.5
10mgl1<9 Omgik9
21.5 23.5
24.5 24.5
25.5 23.0
24.5 21.5
23.0
lmgJL
24.0
22.5
10mgJl OmgJI.
23.5 22.5
24.0 26.5
21.5 20.5
24.5
24.0
Anava: Single Factor
SUMMARY
Groups
Column 1
Column 2
Column 3
Column 4
Column 5
Column 6
Count
1
5
4
2
3
5
Sum
22.5
119.0
92.5
46.5
69.0
118.0
Average Variance
22.50
23.80 2.45
23.13 1.56
23.25 1.13
23.00 1.75
23.60 5.05
ANOVA
Source of SS rtf MS F P-value Ferit
Variation
Between Groups 2.63 5 0.53 0.187 0.963 2.958
WrthinGroups 39.31 14 2.81
Total 41.94 19
Appendix F: Chi4quare (x2) distributions for
survival of fish and glucan treatment.
Day 1
expected:
0.80
Day 14
0.05
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